Focus: Coronavirus Channel Featured Story TOP

Filters close
27-Jul-2020 12:05 PM EDT
Young Kids Could Spread COVID-19 As Much As Older Children and Adults
Ann and Robert H. Lurie Children's Hospital of Chicago

A study from Ann & Robert H. Lurie Children’s Hospital of Chicago discovered that children younger than 5 years with mild to moderate COVID-19 have much higher levels of genetic material for the virus in the nose compared to older children and adults. Findings, published in JAMA Pediatrics, point to the possibility that the youngest children transmit the virus as much as other age groups. The ability of younger children to spread COVID-19 may have been under-recognized given the rapid and sustained closure of schools and daycare during the pandemic.

Newswise:Video Embedded new-study-explores-how-coronavirus-travels-indoors
VIDEO
Released: 28-Jul-2020 10:55 AM EDT
New study explores how coronavirus travels indoors
University of Minnesota College of Science and Engineering

A new study from the University of Minnesota College of Science and Engineering analyzes how the coronavirus spreads indoors—information that could help businesses and schools take precautions to reduce the chance of COVID-19 transmission as they reopen.

Newswise: A Nanomaterial Path Forward for COVID-19 Vaccine Development
15-Jul-2020 5:00 AM EDT
A Nanomaterial Path Forward for COVID-19 Vaccine Development
University of California San Diego

From mRNA vaccines entering clinical trials, to peptide-based vaccines and using molecular farming to scale vaccine production, the COVID-19 pandemic is pushing new and emerging nanotechnologies into the frontlines and the headlines. Nanoengineers at UC San Diego detail the current approaches to COVID-19 vaccine development, and highlight how nanotechnology has enabled these advances, in a review article in Nature Nanotechnology published July 15.

Newswise: COVID-19: Patients Improve After Immune-Suppressant Treatment
Released: 14-Jul-2020 9:05 PM EDT
COVID-19: Patients Improve After Immune-Suppressant Treatment
Cedars-Sinai

Most patients hospitalized with COVID-19 (coronavirus) pneumonia experienced improvement after receiving a Food and Drug Administration-approved drug normally given for rheumatoid arthritis, according to an observational study at Cedars-Sinai. Outcomes for patients who received the drug, tocilizumab, included reduced inflammation, oxygen requirements, blood pressure support and risk of death, compared with published reports of illness and death associated with severely ill COVID-19 patients.

10-Jul-2020 9:00 AM EDT
Long-term strategies to control COVID-19 pandemic must treat health and economy as equally important, argue researchers
University of Cambridge

Strategies for the safe reopening of low and middle-income countries (LMICs) from months of strict social distancing in response to the ongoing COVID-19 pandemic must recognise that preserving people’s health is as important as reviving the economy, argue an international team of researchers.

Released: 7-Jul-2020 2:00 PM EDT
Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors (PPIs)
American College of Gastroenterology (ACG)

Findings from an online survey of more than 53,000 American adults suggest that using heartburn medications known as proton pump inhibitors (PPIs) once or twice daily significantly increases the odds of a positive test for COVID-19 compared to those who do not take PPIs. This research appeared online July 7, 2020 in pre-print format in The American Journal of Gastroenterology.

Newswise: Newer variant of COVID-19–causing virus dominates global infections
Released: 2-Jul-2020 12:10 PM EDT
Newer variant of COVID-19–causing virus dominates global infections
Los Alamos National Laboratory

Research out today in the journal Cell shows that a specific change in the SARS-CoV-2 coronavirus virus genome, previously associated with increased viral transmission and the spread of COVID-19, is more infectious in cell culture.

Newswise:Video Embedded seeing-is-believing-effectiveness-of-facemasks2
VIDEO
29-Jun-2020 10:10 AM EDT
Seeing is Believing: Effectiveness of Facemasks
Florida Atlantic University

Using flow visualization of emulated coughs and sneezes, researchers assessed the efficacy of facemasks in obstructing droplets. Loosely folded facemasks and bandana-style coverings provide minimal stopping-capability for the smallest aerosolized respiratory droplets. Well-fitted homemade masks with multiple layers of quilting fabric, and off-the-shelf cone style masks, proved to be the most effective in reducing droplet dispersal. Importantly, uncovered coughs were able to travel noticeably farther than the currently recommended 6-foot distancing guideline. Without a mask, droplets traveled more than 8 feet.

Newswise: New Research Confirms Higher Rates of New Coronavirus in Latinx Populations
Released: 23-Jun-2020 8:15 AM EDT
New Research Confirms Higher Rates of New Coronavirus in Latinx Populations
Johns Hopkins Medicine

In a new analysis of SARS-CoV-2, the virus that causes COVID-19, test results for nearly 38,000 people has found a positivity rate among Latinx populations about three times higher than for any other racial and ethnic group. The findings, published June 18 in the Journal of the American Medical Association (JAMA), add to evidence that there are much higher COVID-19 infection rates among U.S. minorities, particularly in Latinx communities.

9-Jun-2020 11:00 AM EDT
Widespread facemask use could shrink the ‘R’ number and prevent a second COVID-19 wave – study
University of Cambridge

• Cambridge-led modelling looks at population-level facemask use. • The more people use facemasks in public, the smaller the ‘R’. • Even basic homemade masks significantly reduce transmission at a population level. • Researchers call for information campaigns – “my mask protects you, your mask protects me” – that encourage the making and wearing of facemasks.

Newswise: Roswell Park to Assess Investigational Immunotherapy Combination in Cancer Patients With COVID-19
Released: 12-May-2020 11:35 AM EDT
Roswell Park to Assess Investigational Immunotherapy Combination in Cancer Patients With COVID-19
Roswell Park Comprehensive Cancer Center

A two-drug immunotherapy combination first proposed by a Roswell Park team as an approach for treating cancer will soon be available to cancer patients with COVID-19 through a clinical trial at the Buffalo, N.Y., cancer center.

Newswise: When Ventilators Don’t Help COVID-19 Patients, This Might
Released: 24-Apr-2020 8:40 AM EDT
When Ventilators Don’t Help COVID-19 Patients, This Might
Michigan Medicine - University of Michigan

Ventilators have gotten a lot of attention in the ongoing fight against COVID-19. But hundreds of hospitals around the world have another, less-publicized weapon that might help some of the most desperately ill patients survive when ventilators aren’t enough. It's called ECMO.

Newswise: COVID-19 U.S. Employment Shocks Likely Larger Than Great Depression
Released: 20-Apr-2020 12:35 PM EDT
COVID-19 U.S. Employment Shocks Likely Larger Than Great Depression
Santa Fe Institute

The U.S. is likely to see a near-term 24% drop in employment, 17% percent drop in wages, and 22% drop in economic activity as a result of the COVID-19 crisis according to a new study. These impacts will be very unevenly distributed, with the bottom quarter of earners at risk of a 42% loss in employment and bearing a 30% share of total wage losses. In contrast, the study estimates the top quarter of earners only risk a 7% drop in employment and an 18% share of wage losses.


Showing results

114 of 14

close
1.0675